Vimarsana
Biggest News Aggregation in the World

Page 3 - Johnm Evans News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johnm Evans. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johnm Evans Today - Breaking & Trending Today

Beam Therapeutics (NASDAQ:BEAM) Announces Earnings Results - Vimarsana News

Beam Therapeutics (NASDAQ:BEAM) Announces Earnings Results

Beam Therapeutics (NASDAQ:BEAM – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported $1.73 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.69) by $2.42, Briefing.com reports. The company had revenue of $316.20 million for the quarter, compared to analysts’ expectations of $34.16 million. Beam Therapeutics had […]

Beam Therapeutics' (BEAM) Outperform Rating Reaffirmed at Wedbush - Vimarsana News

Beam Therapeutics' (BEAM) Outperform Rating Reaffirmed at Wedbush

Beam Therapeutics (NASDAQ:BEAM – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Wedbush in a note issued to investors on Tuesday, RTT News reports. They presently have a $57.00 price objective on the stock, up from their prior price objective of $48.00. Wedbush’s price objective would suggest a potential upside of […]

Beam Therapeutics (NASDAQ:BEAM) Trading Down 8.9% - Vimarsana News

Beam Therapeutics (NASDAQ:BEAM) Trading Down 8.9%

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) fell 8.9% during mid-day trading on Tuesday . The company traded as low as $30.30 and last traded at $30.44. 405,654 shares traded hands during mid-day trading, a decline of 66% from the average session volume of 1,195,352 shares. The stock had previously closed at $33.40. Analysts […]

Source: wkrb13.com
Clarius Group LLC Boosts Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM) - Vimarsana News

Clarius Group LLC Boosts Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)

Clarius Group LLC raised its position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) by 115.6% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 60,615 shares of the company’s stock after purchasing an additional 32,504 shares during the quarter. Clarius Group […]

 - Vimarsana News

YEREVAN, JUNE 22, ARMENPRESS. The Tom Lantos Human Rights Commission of the U.S. Congress has held a hearing on Safeguarding the People of Nagorno-Karabakh.